The national Cardiovascular Health Leadership Research Forum: a new data‐driven model placing research at the centre of improving patient outcomes DOI Creative Commons
Gemma A. Figtree,

Kerry Doyle,

Lee Nedkoff

et al.

The Medical Journal of Australia, Journal Year: 2024, Volume and Issue: 221(9), P. 452 - 456

Published: Oct. 15, 2024

The Australian health system is recognised as one of the best globally. However, burden chronic disease, including cardiovascular disease (CVD), remains high and associated care sector spend in Australia rapidly expanding. In 2022–2023, Commonwealth expenditure was estimated at $132 billion, representing 16.8% total budget.1 Over $14 billion spent on direct costs CVD per annum.2 Developing new models to harness immense research resources available tackle our nation's key challenges has potential accelerate implementation drive preventive therapeutic strategies foster a vibrant medical technology ecosystem, thereby, positively affecting patient economic outcomes. Until now, there been no mechanism that allows for fully integrated national conversation stroke between system, clinicians, researchers, industry partners, state federal governments, data economics experts. establishment Cardiovascular Health Leadership Research Forum (CV HLRF) 20223 provides opportunities relevant broad range these stakeholders, connecting leaders from all jurisdictions world class researchers. CV HLRF designed hosted by Alliance (ACvA) — peak body ACvA established coordinated solution-focused model across its Flagships Clinical Themes initiatives (Box). It supported senior leadership engagement Commonwealth, territory jurisdictions, cash contribution number jurisdictions. commitment date about $1.5 million 2025–2026. This funding supplemented philanthropy membership fees, well towards specific initiatives. engaged bodies Australia, National Heart Foundation (NHFA), Stroke Foundation, Cardiac Registry, Institute Welfare, Commission Safety Quality Care, who are committed achieving unprecedented levels collaboration shared goal optimal care. also endorsed Chief Executives Forum. ACT = Capital Territory; cardiovascular; NHFA Australia; NSWCVRN New South Wales Network; NT Northern QCVRN Queensland SACVRN TAS Tasmania; VIC Victoria; WACRA Western Alliance. There already wealth information clinical quality improvement, but often fragmented, lack robust metadata unable be accessed systematic timely manner. Visualisation simplified standardised outcomes indicators will optimise utility leaders, working with researchers consumers prioritise solve challenges. Disaggregated analysis such resource allow identification inequities. particularly improving Aboriginal Torres Strait Islander Peoples, people culturally linguistically diverse backgrounds, regional, rural remote populations, inequities driven sex gender differences socio-economic status. Such can guide tailored approaches pathways groups greatest or inequity addition, inform longer term solutions, identifying where fundamental mechanistic studies needed unravel missing biology, development diagnostic tools, novel drug device solutions. international have led evidence-based guidelines.4-7 way comprehensively measuring compliance guideline recommendations interpreting impacts guideline-based Harmonising efforts consensus standardising outcome organisations enhance participation global stage improved heart includes societies associations American College Cardiology, Association8 European Society Cardiology,9 as, more recently, International Consortium Outcomes Measurement (ICHOM).10 identified five initial patient-focused optimisation flow presentation HLRF: coronary artery disease/acute syndrome, stroke, failure, arrhythmia, sudden cardiac death. All different stages regarding consensus. Even achieved, it only aspect journey (eg, acute syndrome agreed primary prevention). major step indicators, enabling near real-time dashboards. These implemented ensure Australians receiving approach line World Federation, which advocating countries an increased focus local monitoring.11 Evolving makes feasible consider automatic population dashboards electronic records (EMR). datasets, Person Level Integrated Data Asset Hub, actively being used moving forwards, provide platforms supporting stroke. Consensus pass clear message providers their responsibility know report reflecting this challenging. A example seen developed field, wide consultation Care.12 few against other than through irregular, retrospective reports, manually populated funded via budgets rather embedded into budgets. collection measures shown evidence how effective be.13, 14 Resetting expectations provider's significant effect. Major efficiencies achieved investing infrastructure skills engineers) facilitate routine extraction EMRs functional Integration EMR would maximise ease value merging registries nationally. Improved coordination additional investment broader improvements health. SWEDEHEART cohort,15 1749 points over 34 000 patients annually (total 1 patients), long follow-up. Insights important changes practice 290 publications, creating "bank knowledge". large biobanks, UK Biobank China Kadoorie Biobank, linked integral relationships genetic, environmental drivers health.16, 17 type trials. continued highlight urgent need prevention treatment strategies. must incremental, require strong vision, leadership, investment. Although competitive streams invested significantly research, addresses prioritised unmet needs leverages partners not maximised. members understand importance team within strategic framework make desired country's rigorously establish priorities implementation, relevance prospectively assess impact real time. support sustainable models, leveraging multiple clearly defines itself providing valuable service improvements. main stream funds 50 years come Medical Endowment Account (MREA) administered Council (NHMRC). Currently, $880 schemes, 10% highly programs. Renowned rigor excellence, NHMRC relies investigators problem presenting proposed solutions so-called bottom-up approach. substantial impactful discoveries innovations NHMRC. translation always clear. Future Fund (MRFF) top-down program complement largely investigator-initiated (bottom-up) $220 MRFF Mission commenced 2021, contributing further advances reducing CVD. accounts less 0.1% cost CVD, we therefore leverage in-kind impact. detailed road map plan incorporated feedback, ambitious collaborations. requires sector-wide if goals achieved. 2023, government announced $3 allocated second ten-year cycle vision: "A informed research". opportunity achieve this, deep states health, community problems. substantially research. $150 ten NSW capacity building, $470 Hospital Victoria. Individual considering state-based aligned models. Supported NHFA, now Networks country. nexus governments sector, focusing jurisdictional Queensland, Tasmania rolling out statewide systems. teams worked closely innovative programs hypertension example. networks align priorities, use existing emerging pragmatic trials evaluation interventions, strategy. benefit immensely grants, move away seeing charitable endeavour, fragmented fashion. What co-investment pipeline appropriate scale problems addressed. Given $14.3 year,2 returns innovation critical informing policies prioritisation future. With current approach, every dollar $3.20 (Deloitte Access Economics estimate18) returned society terms better Notably, highest return NHMRC-funded workforce yielding $9.80 invested.18 enhanced HLRF. benefits data-driven, thriving addressing globe's challenge quantifiable. Philanthropy ready embrace scale. An exemplar area Snow continues play role recognition embed system. During coronavirus 2019 (COVID-19) pandemic, COVID-19 Cabinet played logical "flattening curve". underpinned coordinating involving chief officers Gathering together experts, helped address hurdle facing Australia: separation care, hospital public states, territories regard, non-communicable diseases. We urgently connects regularly updated essential indicators. does just allowing funders invest in, implement, areas. Prioritisation level agility resourcing change management standard breed clinician-researcher multifaceted perspectives, playing decision making developing stronger culture mentoring early mid-career clinician To shift, standardisation minimum required monitoring services essential. Once articulated endorsed, they should monitored individual jurisdiction each equity. activity. help generated needs, measurable Commitment critical. Demonstrating resulting shift dial both benefits, future decisions, translational ecosystem. Writing group: complete writing group responsible manuscript were: Gemma Figtree1,2,3,4 Kerry Doyle4,5,6 David Brieger3,7 Dominique Cadilhac4,8,9,10 Chant11 Derek Chew4,10,12,13 Clara Chow3,14 Seana Gall4,13,15,16 Kim Greaves17,18,19,20 Garry Jennings3 Stefan Larson21,22,23 Jean-Frederic Levesque11,24 Keith McNeil25 Lee Nedkoff4,26,27 Stephen J Nicholls12,13,28 Miriam Lum On29 Julie Redfern3,4,30 Christian Verdicchio3,31,32 T Vernon1,2,3 Zoe Wainer33,34 Jason Kovacic4,24,26,27,35,36,37 Kolling Research, University Sydney, NSW. 2 Royal North Shore Hospital, 3 4 Alliance, 5 Australasian 6 Complementary Medicines, 7 8 Victorian Institute, Monash University, Melbourne, VIC. 9 Health, 10 Florey Neuroscience Mental 11 Ministry 12 13 Westmead Applied Centre (CKC), 15 Menzies Hobart, TAS. 16 Tasmania, Brisbane, QLD. 18 Sunshine Coast Buderim, 19 Canberra, ACT. 20 Services, Birtinya, 21 Measurement, Boston (MA), USA. 22 Karolinska Solna, Sweden. 23 Consulting Group, 24 UNSW 25 Excellence Innovation Adelaide, SA. 26 Victor Chang 27 Perth, WA. 28 MonashHeart, 29 30 George Global 31 Support 32 33 Department 35 St Vincent's 36 Association Institutes, 37 Icahn School Medicine Mount Sinai, York (NY), USA received Government Funding non-profit study. Not commissioned; externally peer reviewed.

Language: Английский

Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study DOI Creative Commons
John W. McEvoy, Catriona Jennings, Kornelia Kotseva

et al.

European Heart Journal, Journal Year: 2024, Volume and Issue: 45(39), P. 4184 - 4196

Published: Aug. 30, 2024

INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in a timely manner. Between 2020 2023, adults hospitalized the preceding 6-24 months with incident or recurrent CHD were sampled 14 countries from all 6 World Health Organization regions invited standardized interview examination. Direct age sex standardization was used country-level prevalence estimation. Overall, 4548 (21.1% female) patients interviewed median 1.05 (interquartile range .76-1.45) years after index hospitalization. Among participants, 24.6% obese (40.7% centrally). Only 38.6% blood pressure (BP) < 130/80 mmHg 16.6% LDL cholesterol (LDL-C) <1.4 mmol/L. Of those smoking at hospitalization, 48% persisted interview. known diabetes, 55.2% glycated haemoglobin (HbA1c) <7.0%. A further 9.8% had undetected diabetes 26.9% impaired glucose tolerance. Females less likely achieve targets: BP (females 36.8%, males 38.9%), LDL-C 12.0%, 17.9%), HbA1c 47.7%, 57.5%). just 9.0% (inter-country 3.8%-20.0%) reported attending 1.0% .0%-2.4%) definition optimal adherence. demonstrates inadequate heterogeneous implementation first year geographic disparity. Investment aimed reducing between-country between-individual variability will promote equity global efforts reduce burden CHD.

Language: Английский

Citations

11

Making Secondary Prevention the Primary Focus for Cardiovascular Disease Control DOI
Oyere K. Onuma

Journal of the American College of Cardiology, Journal Year: 2025, Volume and Issue: 85(5), P. 451 - 453

Published: Feb. 1, 2025

Language: Английский

Citations

1

PURE Evidence in Plain Sight DOI
Abhishek Chaturvedi, Dorairaj Prabhakaran

Journal of the American College of Cardiology, Journal Year: 2025, Volume and Issue: 85(5), P. 448 - 450

Published: Feb. 1, 2025

Language: Английский

Citations

1

Cardiovascular Effects of Smoking and Smoking Cessation: A 2024 Update DOI Creative Commons

Mahfuzur Rahman,

Mohammad Alatiqi,

Mohammed Al‐Jarallah

et al.

Global Heart, Journal Year: 2025, Volume and Issue: 20(1)

Published: Jan. 1, 2025

Smoking is a significant risk factor for both acute and chronic cardiovascular diseases. These diseases contribute to approximately twenty percent of all-cause mortality. Research indicates that quitting smoking can substantially reduce or even reverse the harmful effects associated with on health. Notably, these benefits be observed in relatively short period compared duration history. This article aims provide data understand system locally as well its pandemic globally hence comprehensive strategies management patients cessation.

Language: Английский

Citations

1

Prevalence and Determinants of Heart Disease in Somaliland: An Analysis of the 2020 Somaliland Demographic and Health Survey (SLDHS) DOI

Hodo Abdikarim,

Mustafe Abdillahi Ali,

Abdirizak Hassan Abokor

et al.

Current Problems in Cardiology, Journal Year: 2024, Volume and Issue: 50(1), P. 102885 - 102885

Published: Oct. 21, 2024

Language: Английский

Citations

5

Medicinal and Aromatic Plants as Potential Sources of Bioactives Along with Health-Promoting Activities DOI

Radha CHAUHAN,

Neeraj Kumari, Suraj Prakash

et al.

Current Food Science and Technology Reports, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 14, 2024

Language: Английский

Citations

4

Study on the Synergistic Effect of Klotho and KRAS on Reducing Ferroptosis After Myocardial Infarction by Regulating RAP1/ERK Signaling Pathway DOI

Cheng-Zhe Cai,

Yangjie Wu, Xiaoqian Feng

et al.

Applied Biochemistry and Biotechnology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 14, 2025

Language: Английский

Citations

0

Online survey of healthcare professionals on the use of digital technology in the secondary prevention of cardiovascular disease in Austria (Preprint) DOI Creative Commons

Luisa Lunz,

Sabine Würth,

Stefan Tino Kulnik

et al.

Published: Jan. 16, 2025

BACKGROUND Advances in digital technology (DT), such as health apps and telerehabilitation systems, offer promising treatment modalities the secondary prevention of cardiovascular disease (CVD). However, successful adoption DT clinical practice depends on a variety factors. A comprehensive understanding influencing factors usage healthcare can support complex implementation process practice. OBJECTIVE This study therefore to identify barriers facilitators CVD from perspective professionals (HCPs), explore whether certain HCP characteristics are related current METHODS An online survey questionnaire, inquiring about perspectives uses DTs prevention, was deployed among Austrian HCPs November 2021 February 2022. RESULTS Overall, 125 across different professions settings, cardiac rehabilitation, were recruited. General readiness for employing care patients high, but only 65 (52%) respondents reported doing so. The top-3 rated use poor user-experience devices/applications, lack cost coverage low competence patients. More personal DT, younger age higher affinity indicated with CONCLUSIONS Our findings provide an overview Austria. HCPs’ may inform design future digitalization projects. CLINICALTRIAL Not applicable

Language: Английский

Citations

0

Objectively Measured Physical Activity among People with and without HIV in Uganda: Associations with Cardiovascular Risk and Coronary Artery Disease DOI Creative Commons

Chinonso C. Opara,

Christine Horvat Davey, Cissy Kityo

et al.

Global Heart, Journal Year: 2025, Volume and Issue: 20(1), P. 13 - 13

Published: Feb. 10, 2025

Background: Africa has a disproportionate burden of HIV-related cardiovascular disease. We aimed to describe physical activity in people living with HIV (PLHIV) and without (PWOH) Uganda characterize its relationship the presence computed tomography angiography-detected (CCTA) coronary artery disease (CAD). Methods: performed cross-sectional analysis Ugandan Study Effects on Myocardium Atherosclerosis using Computed Tomography (mUTIMA-CT) cohort. From 2017–2019, PLHIV PWOH was assessed by accelerometry over seven days. Participants additionally underwent CCTA. Univariable multivariable modified Poisson regression used analyze between CAD presence. Results: 168 participants were analyzed. The median (IQR) age 57 (53–58) years old 64% female. Males had more moderate-to-vigorous per week [68 minutes (12–144) vs. 15 (0–50), P < 0.001] less light [788 (497–1,202) [1,059 (730–1490), = compared females, but there no difference status. After adjusting for age, which accounted 10% variation steps taken, sex, significant associations found plaque. Conclusion: Objectively measured low guideline recommendations, males being somewhat active than females differences Physical not associated independently sex.

Language: Английский

Citations

0

The impact of oxidative stress on abnormal lipid metabolism-mediated disease development DOI
Lanlan Li,

Zhiliang Guo,

Yi Zhao

et al.

Archives of Biochemistry and Biophysics, Journal Year: 2025, Volume and Issue: unknown, P. 110348 - 110348

Published: Feb. 1, 2025

Language: Английский

Citations

0